Stay updated on Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.

Latest updates to the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page
- Check5 days agoChange DetectedThe page version is updated from v3.0.1 to v3.0.2. The 'Back to Top' element has been removed.SummaryDifference0.2%
- Check12 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and specific locations related to the study on bullous pemphigoid, while also removing several previous location references.SummaryDifference5%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check48 days agoChange DetectedThe page has updated its version from v2.16.8 to v2.16.10 and added new dates for certification and extensions, while removing previous dates and a service alert regarding planned maintenance.SummaryDifference2%
Stay in the know with updates to Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.